Search

Displaying results 5841 - 5850 of 9322 in total
  1. Drug

    Pexantel

    go.drugbank.com/drugs/DB20771
    Experimental

    The usage of the INN stem '-antel' in the name indicates that Pexantel is a anthelminthic. Pexantel has a monoisotopic molecular weight of 210.17 Da.

  2. Drug

    Zilantel

    go.drugbank.com/drugs/DB20793
    Experimental

    The usage of the INN stem '-antel' in the name indicates that Zilantel is a anthelminthic. Zilantel has a monoisotopic molecular weight of 664.11 Da.

  3. Drug

    Haloprogesterone

    go.drugbank.com/drugs/DB20259
    Experimental

    The usage of the INN stem '-terone' in the name indicates that Haloprogesterone is a antiandrogen. Haloprogesterone has a monoisotopic molecular weight of 410.13 Da.

  4. Drug

    Belfosdil

    go.drugbank.com/drugs/DB21327
    Experimental

    The usage of the INN stem '-dil' in the name indicates that Belfosdil is a vasodilator. Belfosdil has a monoisotopic molecular weight of 548.3 Da.

  5. Drug

    Litomeglovir

    go.drugbank.com/drugs/DB21363
    Experimental

    The usage of the INN stem '-vir' in the name indicates that Litomeglovir is a antiviral. Litomeglovir has a monoisotopic molecular weight of 498.19 Da.

  6. Drug

    Norgesterone

    go.drugbank.com/drugs/DB21409
    Experimental

    The usage of the INN stem '-terone' in the name indicates that Norgesterone is a antiandrogen. Norgesterone has a monoisotopic molecular weight of 300.21 Da.

  7. Drug

    Pitenodil

    go.drugbank.com/drugs/DB21442
    Experimental

    The usage of the INN stem '-dil' in the name indicates that Pitenodil is a vasodilator. Pitenodil has a monoisotopic molecular weight of 353.18 Da.

  8. Drug

    Calusterone

    go.drugbank.com/drugs/DB01564
    ExperimentalIllicit

    A 17-alkylated orally active androgenic steroid. A Schedule IV drug in Canada.

  9. Drug

    ChulaCov19 mRNA vaccine

    go.drugbank.com/drugs/DB16445
    Experimental

    The ChulaCov19 vaccine is mRNA-based and was developed in Thailand’s Chulalongkorn University in collaboration with the University of Pennsylvania in the US[L30673, L30678]. … The next phase of this study is for phase I and II clinical trials (NCT04566276) beginning in January 2021.

  10. Drug

    Cetilistat

    go.drugbank.com/drugs/DB06586
    Investigational

    Cetilistat is a novel inhibitor of pancreatic lipase being developed by Alizyme for the treatment of obesity and associated co-morbidities, including type 2 diabetes.